These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 7508010)

  • 41. Characterization of the neutralizing activity of digoxin-specific Fab toward ouabain-like steroids.
    Pullen MA; Brooks DP; Edwards RM
    J Pharmacol Exp Ther; 2004 Jul; 310(1):319-25. PubMed ID: 14982968
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The ouabain receptor in animal tissues and its endogenous ligand.
    Lichtstein D; Samuelov S; Deutsch J; Xu H; Lutz RA; Chernick SS; Chernick SS
    Klin Wochenschr; 1987; 65 Suppl 8():40-8. PubMed ID: 3037184
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inhibitors of Na-K-ATPase in human urine: effects of ouabain-like factors and of vanadium-diascorbate on calcium mobilization in rat vascular smooth muscle cells: comparison with the effects of ouabain, angiotensin II, and arginine-vasopressin.
    Meyer-Lehnert H; Bäcker A; Kramer HJ
    Am J Hypertens; 2000 Apr; 13(4 Pt 1):364-9. PubMed ID: 10821337
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Identification of a ouabain-like compound in toad skin and plasma as a bufodienolide derivative.
    Lichtstein D; Kachalsky S; Deutsch J
    Life Sci; 1986 Apr; 38(14):1261-70. PubMed ID: 3007907
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ouabainlike factor in Milan hypertensive rats.
    Ferrandi M; Minotti E; Salardi S; Florio M; Bianchi G; Ferrari P
    Am J Physiol; 1992 Oct; 263(4 Pt 2):F739-48. PubMed ID: 1329560
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of chronic ouabain infusion on food, water, and NaCl intake, body composition, and plasma hormones of Sprague-Dawley rats.
    Tordoff MG
    Physiol Behav; 1996 Jan; 59(1):87-92. PubMed ID: 8848496
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ouabain-inhibiting activity of aldosterone antagonists.
    Semplicini A; Serena L; Valle R; Ceolotto G; Felice M; Fontebasso A; Pessina AC
    Steroids; 1995 Jan; 60(1):110-3. PubMed ID: 7792794
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inhibition of Na/K ATPase from rat aorta by two Na/K pump inhibitors, ouabain and marinobufagenin: evidence of interaction with different alpha-subunit isoforms.
    Fedorova OV; Bagrov AY
    Am J Hypertens; 1997 Aug; 10(8):929-35. PubMed ID: 9270089
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Sodium pump inhibition and regional expression of sodium pump alpha-isoforms in lens.
    Tao QF; Hollenberg NK; Graves SW
    Hypertension; 1999 Nov; 34(5):1168-74. PubMed ID: 10567200
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Identification of two cardiac glycosides as Na(+)-pump inhibitors in rat urine and diet.
    Tamura M; Harris TM; Phillips D; Blair IA; Wang YF; Hellerqvist CG; Lam SK; Inagami T
    J Biol Chem; 1994 Apr; 269(16):11972-9. PubMed ID: 8163500
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of ouabain on the pressor response to phenylephrine and on the sodium pump activity in diabetic rats.
    Davel AP; Rossoni LV; Vassallo DV
    Eur J Pharmacol; 2000 Oct; 406(3):419-27. PubMed ID: 11040349
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Chronic ouabain infusion does not cause hypertension in sheep.
    Pidgeon GB; Richards AM; Nicholls MG; Charles CJ; Rademaker MT; Lynn KL; Bailey RR; Lewis LK; Yandle TG
    Am J Physiol; 1996 Mar; 270(3 Pt 1):E386-92. PubMed ID: 8638682
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Endogenous Na+ transport inhibitor in human hypertension: further biochemical and chemical studies.
    Cloix JF; Crabos M; Grichois ML; Guicheney P; Meyer P
    Klin Wochenschr; 1987; 65 Suppl 8():146-53. PubMed ID: 3037183
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Increase in plasma ouabainlike inhibitor of Na+, K+-ATPase with high sodium intake in patients with essential hypertension.
    Hasegawa T; Masugi F; Ogihara T; Kumahara Y
    J Clin Hypertens; 1987 Dec; 3(4):419-29. PubMed ID: 2839625
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The influence of nanomolar ouabain on vascular pressor responses is modulated by the endothelium.
    Rossoni LV; Cunha V; Franca A; Vassallo DV
    J Cardiovasc Pharmacol; 1999 Dec; 34(6):887-92. PubMed ID: 10598134
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Role of endogenous brain "ouabain" in the sympathoexcitatory and pressor effects of sodium.
    Van Huysse JW; Leenen FH
    Clin Exp Hypertens; 1998; 20(5-6):657-67. PubMed ID: 9682921
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Endogenous sodium pump inhibitors and blood pressure regulation: an update on recent progress.
    Doris PA; Bagrov AY
    Proc Soc Exp Biol Med; 1998 Jul; 218(3):156-67. PubMed ID: 9648933
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Endogenous ligand of alpha(1) sodium pump, marinobufagenin, is a novel mediator of sodium chloride--dependent hypertension.
    Fedorova OV; Talan MI; Agalakova NI; Lakatta EG; Bagrov AY
    Circulation; 2002 Mar; 105(9):1122-7. PubMed ID: 11877366
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Characteristics of a ouabain-like factor from Milan hypertensive rats.
    Ferrandi M; Minotti E; Salardi S; Florio M; Bianchi G; Ferrari P
    J Cardiovasc Pharmacol; 1993; 22 Suppl 2():S75-8. PubMed ID: 7508036
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Endogenous cardiac glycosides: hormones using the sodium pump as signal transducer.
    Schoner W; Scheiner-Bobis G
    Semin Nephrol; 2005 Sep; 25(5):343-51. PubMed ID: 16139690
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.